Shattuck Labs(STTK) - 2025 Q1 - Quarterly Results

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights AUSTIN, TX and DURHAM, NC, May 01, 2025 – Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today reported financial results for the first quarter ended March 31, 2025 and provided recent business highlights. Recen ...